APOA4 and heart failure: For all outcomes, hs‐CRP significantly mediated the effect of apoA‐IV (already adjusted using the variables from adjustment model 2) by roughly 31% (all‐cause mortality) to 40%–44% (3‐point MACE, death and hospitalisation due to heart failure and 4‐point MACE in ascending order) (Fig. 3).